Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

84.17 -1.42 (-1.66%)
Streaming Delayed Price Updated: 9:35 AM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
7 Oversold Russell 2000 Stocks to Add to Your February Buy List ↗
Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong. 
Via InvestorPlace
News headline image
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
Via Investor's Business Daily
News headline image
7 Biotech Stocks Fighting America’s Deadliest Diseases ↗
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship. 
Via InvestorPlace
News headline image
Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Recap: Arrowhead Pharma Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 6, 2024 ↗
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
News headline image
4 Analysts Assess Arrowhead Pharma: What You Need To Know ↗
 
Via Benzinga
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
News headline image
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
Via Benzinga
Topics Stocks
News headline image
Why Arrowhead Pharmaceuticals Shares Are Moving ↗
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79... 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Arrowhead Pharma ↗
 
Via Benzinga
News headline image
Recap: Arrowhead Pharma Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Arrowhead Pharma ↗
 
Via Benzinga
News headline image
Analyst Expectations for Arrowhead Pharma's Future ↗
 
Via Benzinga
News headline image
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. 
Via Benzinga
News headline image
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a... 
Via Benzinga
Topics Stocks
News headline image
Analyst Ratings for Arrowhead Pharma ↗
 
Via Benzinga
News headline image
Analyst Expectations for Arrowhead Pharma's Future ↗
 
Via Benzinga
News headline image
Expert Ratings for Arrowhead Pharma ↗
 
Via Benzinga
News headline image
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback ↗
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals. 
Via Benzinga
News headline image
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. 
Via Benzinga
News headline image
Earnings Scheduled For November 29, 2023 ↗
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million. 
Via Benzinga
News headline image
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK ↗
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023 ↗
 
Via Benzinga
News headline image
Cramer Says 'Please Stay Away' From This EV Maker, It 'Should Not Be Public' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norfolk Southern Corporation (NYSE: NSC) is the "cheapest I’ve seen in a very long time, 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗
 
Via Benzinga
News headline image
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million ↗
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A. 
Via Investor's Business Daily
News headline image
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
News headline image
Arrowhead CEO Christopher Anzalone Addresses The 'Really Important Event' In Lung Disease ↗
Arrowhead CEO Christopher Anzalone discusses expectations for ARO-RAGE in lung disease. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.